19h
GlobalData on MSNPrecision reports initial outcomes from Hepatitis B trial of PBGENE-HBVThe trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.
Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.
Precision BioSciences (DTIL) announced initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level of the ...
Hosted on MSN3mon
Promising New Data from Hepatitis B Trial by Arbutus and BarinthusNotably, those who received nivolumab exhibited higher rates of hepatitis B surface antigen (HBsAg) loss compared to other groups. This is seen as a significant step forward in targeting HBsAg ...
HBV reactivation (HBVr) occurs when HBV activity is no longer suppressed by the immune system in people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc).
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...
We similarly followed 16 children of hepatitis B surface antigen (HBsAg)-positive mothers. Results: Of low risk infants receiving a plasma-derived vaccine, 41% (42 of 102) of those whose primary ...
Antibody concentrations ≥10mIU/mL against HBsAg are recognized as conferring protection against hepatitis B virus infection. Give IM in deltoid muscle. 11–19yrs: 10mcg at elected date and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results